BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ali RH, Al-safi R, Al-waheeb S, John B, Al-ali W, Al-jassar W, Al-mulla F, Melnyk N, Huntsman DG, Lee C. Molecular characterization of a population-based series of endometrial stromal sarcomas in Kuwait. Human Pathology 2014;45:2453-62. [DOI: 10.1016/j.humpath.2014.08.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Yamaguchi K. Personalized Treatment in Uterine Sarcoma. Personalization in Gynecologic Oncology 2022. [DOI: 10.1007/978-981-19-4711-7_4] [Reference Citation Analysis]
2 Mohammad N, Stewart CJR, Chiang S, Turashvili G, Dickson BC, Ng TL, Köbel M, McCluggage WG, Croce S, Lee CH. p53 immunohistochemical analysis of fusion-positive uterine sarcomas. Histopathology 2021;78:805-13. [PMID: 33118176 DOI: 10.1111/his.14292] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
3 Oliva E, Zaloudek CJ, Soslow RA. Mesenchymal Tumors of the Uterus. In: Kurman RJ, Hedrick Ellenson L, Ronnett BM, editors. Blaustein's Pathology of the Female Genital Tract. Cham: Springer International Publishing; 2019. pp. 535-647. [DOI: 10.1007/978-3-319-46334-6_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
4 Howitt BE, Nucci MR. Uterine Mesenchymal Lesions. Gynecologic and Obstetric Pathology, Volume 2 2019. [DOI: 10.1007/978-981-13-3019-3_1] [Reference Citation Analysis]
5 Hoang L, Chiang S, Lee C. Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations. Pathology 2018;50:162-77. [DOI: 10.1016/j.pathol.2017.11.086] [Cited by in Crossref: 68] [Cited by in F6Publishing: 74] [Article Influence: 17.0] [Reference Citation Analysis]
6 Oliva E, Zaloudek CJ, Soslow RA. Mesenchymal Tumors of the Uterus. Blaustein's Pathology of the Female Genital Tract 2018. [DOI: 10.1007/978-1-4614-3165-7_10-2] [Reference Citation Analysis]
7 Ritterhouse LL, Howitt BE. Molecular Pathology: Predictive, Prognostic, and Diagnostic Markers in Uterine Tumors. Surg Pathol Clin 2016;9:405-26. [PMID: 27523969 DOI: 10.1016/j.path.2016.04.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
8 Howitt BE, Nucci MR. Molecular Pathology of Uterine Mesenchymal Tumors. Molecular Pathology Library 2017. [DOI: 10.1007/978-3-319-57985-6_11] [Reference Citation Analysis]
9 Li X, Anand M, Haimes JD, Manoj N, Berlin AM, Kudlow BA, Nucci MR, Ng TL, Stewart CJR, Lee C. The application of next-generation sequencing-based molecular diagnostics in endometrial stromal sarcoma. Histopathology 2016;69:551-9. [DOI: 10.1111/his.12966] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
10 Hrzenjak A. JAZF1/SUZ12 gene fusion in endometrial stromal sarcomas. Orphanet J Rare Dis 2016;11:15. [PMID: 26879382 DOI: 10.1186/s13023-016-0400-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
11 Ali RH, Rouzbahman M. Endometrial stromal tumours revisited: an update based on the 2014 WHO classification. J Clin Pathol. 2015;68:325-332. [PMID: 25595274 DOI: 10.1136/jclinpath-2014-202829] [Cited by in Crossref: 73] [Cited by in F6Publishing: 79] [Article Influence: 10.4] [Reference Citation Analysis]